Global Synthetic Biology Market to Reach US$99.4 Billion by 2032 Driven by Advances in Genome Engineering and Industrial Biotechnology
The global Synthetic Biology market is witnessing strong momentum as advances in biological engineering, genome editing, DNA synthesis, and computational biology continue to expand commercial opportunities across healthcare, industrial manufacturing, and environmental applications. Synthetic biology has emerged as a transformative discipline that combines engineering principles with molecular biology to design new biological systems capable of solving complex global challenges. According to Industry Experts, Inc’s latest market analysis, the Synthetic Biology market was valued at US$26.6 billion in 2025 and is forecast to reach US$99.4 billion by 2032, growing at a CAGR of 20.7% during the forecast period. Growing investments in biotechnology research and increasing commercialization of engineered biological solutions are supporting sustained market expansion. Genome Engineering remains the leading technology segment, accounting for 42.7% of market revenue in 2025, whi...